3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
47
Carcinoma, Non-Small-Cell Lung
30
Pancreatic Neoplasms
24
Ovarian Neoplasms
23
Fallopian Tube Neoplasms
21
Triple Negative Breast Neoplasms
15
Breast Neoplasms, Male
14
Brenner Tumor
12
Melanoma
10
Carcinoma, Ovarian Epithelial
10
Unspecified Adult Solid Tumor, Protocol Specific
8
Lung Neoplasms
8
Uterine Cervical Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Adenocarcinoma of Lung
7
Urinary Bladder Neoplasms
6
Neoplasms
6
Adenocarcinoma, Bronchiolo-Alveolar
6
Neoplasm Metastasis
5
Stomach Neoplasms
4
Esophageal Neoplasms
4
Endometrial Neoplasms
4
Cholangiocarcinoma
4
Pleural Effusion, Malignant
3
Inflammatory Breast Neoplasms
3
Gallbladder Neoplasms
3
Carcinoma, Transitional Cell
3
Uveal Melanoma
2
Tongue Neoplasms
2
Thymoma
2
Interventions
Cyclophosphamide
10
Irinotecan
8
Melphalan
7
Vincristine
6
Temozolomide
6
Doxorubicin
6
Busulfan
6
Topotecan
5
Granulocyte Colony-Stimulating Factor
5
Gemcitabine
5
Ifosfamide
4
Filgrastim
4
Etoposide
4
Albumin-Bound Paclitaxel
4
Trabectedin
3
Sirolimus
3
Nivolumab
3
130-nm albumin-bound paclitaxel
3
pegfilgrastim
2
olaparib
2
fludarabine phosphate
2
fludarabine
2
eribulin
2
cixutumumab
2
abemaciclib
2
X-Rays
2
Radiotherapy, Intensity-Modulated
2
Peripheral Blood Stem Cell Transplantation
2
Magnetic Resonance Spectroscopy
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcoma, Ewing
×
Taxes
×
Clear all
NCT03275818
2022-06-07
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Phase 2
Completed
69 enrolled